跳至主要内容
临床试验/NL-OMON26223
NL-OMON26223招募中不适用

IMIT-1: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial

S.E. Vermeer, MD, PhD0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Men or women 18 years and over;
  • 2. TIA/minor ischemic stroke (modified Rankin Score 3 or less) within 6
  • 3. Impaired fasting glucose (fasting glucose level of 5.6 to 6.9 mmol/L) and/or impaired glucose tolerance (2-hour post-load glucose level of 7.8 to 11.0 mmol/L);
  • 4. Informed consent

排除标准

  • 1. Known or newly diagnosed diabetes mellitus;
  • 2. Contraindication for metformin:
  • a. renal impairment (serum creatinine >135 micromol/L for men, and >110
  • micromol/L for women),
  • b. hepatic disease (liver enzymes increased twice the upper limit of normal), c. a past history of lactic acidosis,
  • d. cardiac failure requiring pharmacological therapy,
  • e. chronic hypoxic lung disease,
  • f. pregnancy,
  • g. breast feeding;
  • 3. Severe comorbidity interfering with follow-up

研究者

发起方
S.E. Vermeer, MD, PhD

相似试验

已完成
不适用
IMIT-1: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose Tolerance and a recent transient ischaemic attack or minor ischaemic stroke: a phase II randomised, controlled trialTransient ischaemic attack or minor ischaemic strokeCirculatory SystemVascular complications
ISRCTN54960762Erasmus Medical Centre (The Netherlands)40
进行中(未招募)
不适用
IMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial - LIMIT phase 2Patients with impaired glucose tolerance and a recent TIA or minor ischemic strokeMedDRA version: 8.1Level: LLTClassification code 10052426Term: Glucose intolerance
EUCTR2006-005772-41-NLinvestigator-driven research: Erasmus MC, Neurovascular Section40
招募中
2 期
IMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trialprediabetesimpaired glucose tolerance1001842410007963
NL-OMON30741Erasmus MC, Universitair Medisch Centrum Rotterdam40
Unknown
不适用
Carotid Atherosclerosis In Newly Diagnosed Type 2 IndividualsType II Diabetes Mellitus Without Mention of Complication
NCT01898572Hospital Clinic of Barcelona200
招募中
不适用
Post-operative exercise training for peripheral arterial diseasePeripheral arterial disease
ACTRN12616001232426niversity of the Sunshine Coast30
IMIT-1: Lowering the Incidence of vascular... | 临床试验